טוען...
VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis
OBJECTIVE: The targeting of negative checkpoint regulators as a means of augmenting antitumor immune responses is now an increasingly used and remarkably effective approach to the treatment of several human malignancies. The negative checkpoint regulator VISTA (V-domain Ig–containing suppressor of T...
שמור ב:
| הוצא לאור ב: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5723399/ https://ncbi.nlm.nih.gov/pubmed/27992697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40020 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|